CTLA4 and Autoimmunity: In addition, combination blockade of PD-1 and VISTA in a mice model did not result in overt autoimmunity, suggesting that this regimen could represent a less toxic alternative to anti-PD-1 and anti-CTLA-4 combination regimens44.